AXSOME THERAPEUTICS INC (AXSM)
US05464T1043 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.04M | 270.6M 440.77% | 392.47M 45.04% | 659.54M 68.05% | 1.128B 71.03% | 1.535B 36.08% | 2.05B 33.55% | 2.397B 16.93% | 2.78B 15.98% | 3.131B 12.63% | ||
| EBITDA YoY % growth | -124.63M -25.74% | -174.9M -40.34% | -224.991M -28.64% | -215.723M 4.12% | 15.54M 107.20% | 296.87M 1,810.36% | 496.84M 67.36% | 739.81M 48.90% | 1.031B 39.36% | 1.255B 21.73% | 1.479B 17.85% | |
| EBIT YoY % growth | -124.71M -25.79% | -179.3M -43.77% | -231.825M -29.29% | -252.315M -8.84% | -61.664M 75.56% | 200.37M 424.94% | 599.7M 199.30% | 1.016B 69.42% | 1.21B 19.09% | 1.548B 27.93% | 1.863B 20.35% | |
| Operating Margin | N/A | -358.31% | -85.67% | -64.29% | -9.35% | 17.76% | 39.07% | 49.56% | 50.48% | 55.68% | 59.50% | |
| EPS YoY % growth | -3.47 -27.11% | -4.57 -31.70% | -5.20 -13.79% | -5.53 -6.31% | -2.32 58.04% | 3.23 239.07% | 8.82 173.53% | 13.23 49.97% | 17.38 31.36% | 22.11 27.19% | 26.52 19.96% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.97 53.52% | -0.98 31.73% | -0.64 61.52% | -0.33 75.45% | 0.10 110.55% | 0.04 104.15% | 0.87 234.92% | 1.57 577.52% | 2.31 2,160.00% |
| Revenue Q2Q % growth | 120.45M 68.39% | 123.9M 65.20% | 146.18M 67.70% | 169.95M 62.22% | 216.36M 79.63% | 203.78M 64.47% | 267.29M 82.85% | 318.94M 87.67% | 372.66M 72.24% |
| EBITDA Q2Q % growth | -29.993M 67.20% | -41.835M 36.07% | -31.283M 57.85% | -25.444M 55.16% | 88.373M 394.64% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -43.859M 55.37% | -42.128M 37.38% | -26.949M 65.47% | -12.625M 79.84% | 21.034M 147.96% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.34 -1.52% | -1.44 | 0.10 | 6.83% |
| Q2 2024 Q2Q % growth | -1.67 -8.44% | -1.36 | -0.31 | -22.89% |
| Q1 2024 Q2Q % growth | -1.44 -453.85% | -1.23 | -0.21 | -17.22% |
| Q4 2023 Q2Q % growth | -2.08 -47.52% | -1.19 | -0.89 | -74.11% |
| Q3 2023 Q2Q % growth | -1.32 -23.36% | -1.23 | -0.09 | -7.52% |
| Q2 2023 Q2Q % growth | -1.54 -45.28% | -1.25 | -0.29 | -23.51% |
| Q1 2023 Q2Q % growth | -0.26 74.76% | -1.06 | 0.80 | 75.39% |
| Q4 2022 Q2Q % growth | -1.41 -56.67% | -1.16 | -0.25 | -21.43% |
| Q3 2022 Q2Q % growth | -1.07 -15.05% | -1.10 | 0.03 | 2.80% |
| Q2 2022 Q2Q % growth | -1.06 -23.26% | -1.23 | 0.17 | 13.97% |
| Q1 2022 Q2Q % growth | -1.03 -32.05% | -1.02 | -0.01 | -0.75% |
| Q4 2021 Q2Q % growth | -0.90 -15.38% | -1.04 | 0.14 | 13.63% |
| Q3 2021 Q2Q % growth | -0.93 -60.34% | -0.97 | 0.04 | 4.06% |
| Q2 2021 Q2Q % growth | -0.86 -75.51% | -0.98 | 0.12 | 12.63% |
| Q1 2021 Q2Q % growth | -0.78 11.36% | -0.88 | 0.10 | 11.84% |
| Q4 2020 Q2Q % growth | -0.78 -9.86% | -0.77 | -0.01 | -0.90% |
| Q3 2020 Q2Q % growth | -0.58 -3.57% | -0.58 | 0.00 | 0.62% |
| Q2 2020 Q2Q % growth | -0.49 -19.51% | -0.63 | 0.14 | 22.07% |
| Q1 2020 Q2Q % growth | -0.88 -175.00% | -0.64 | -0.24 | -38.16% |
| Q4 2019 Q2Q % growth | -0.71 -121.87% | -0.49 | -0.22 | -45.02% |
| Q3 2019 Q2Q % growth | -0.56 -80.65% | -0.41 | -0.15 | -36.83% |
| Q2 2019 Q2Q % growth | -0.41 -28.12% | -0.33 | -0.08 | -23.05% |
| Q1 2019 Q2Q % growth | -0.32 -68.42% | -0.30 | -0.02 | -5.99% |
| Q4 2018 Q2Q % growth | -0.32 | -0.30 | -0.02 | -5.45% |
| Q3 2018 Q2Q % growth | -0.31 | -0.29 | -0.02 | -6.02% |
| Q2 2018 Q2Q % growth | -0.32 | -0.30 | -0.02 | -6.35% |
| Q1 2018 Q2Q % growth | -0.19 | -0.29 | 0.10 | 33.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 104.762M 81.27% | 100.94M | 3.822M | 3.79% |
| Q2 2024 Q2Q % growth | 87.166M 89.42% | 88.66M | -1.494M | -1.69% |
| Q1 2024 Q2Q % growth | 74.999M -20.70% | 74.761M | 238K | 0.32% |
| Q4 2023 Q2Q % growth | 71.531M 193.52% | 68.915M | 2.616M | 3.80% |
| Q3 2023 Q2Q % growth | 57.794M 242.99% | 55.959M | 1.835M | 3.28% |
| Q2 2023 Q2Q % growth | 46.017M 421.73% | 41.753M | 4.264M | 10.21% |
| Q1 2023 Q2Q % growth | 94.576M | 26.591M | 67.985M | 255.67% |
| Q4 2022 Q2Q % growth | 24.37M | 22.195M | 2.175M | 9.80% |
| Q3 2022 Q2Q % growth | 16.85M | 16.968M | -118K | -0.70% |
| Q2 2022 Q2Q % growth | 8.82M | 6.418M | 2.402M | 37.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10.92% | -10.92% | 5.02% | 2.28% |
| Revenue | 1.59% | 1.59% | 3.11% | 1.78% |